Drug intelligence / Profile preview

National Inst. of Pharma Education and Research (NIPER) VEGFR-2 compound 8u

Development stage
Unknown
Lead developer
National Institute of Pharmaceutical Education and Research
01

Overview

National Inst. of Pharma Education and Research (NIPER) VEGFR-2 compound 8u: sourced facts only. name: "Further, VEGFR inhibition assay revealed that the compound 8u inhibited VEGFR-2 kinase with an IC50 of 1.52 ± 0.08 μM, comparable to the standard drug sunitinib (1.2 ± 0.07 μM)." [PMID:40712230]; target: "Further, VEGFR inhibition assay revealed that the compound 8u inhibited VEGFR-2 kinase with an IC50 of 1.52 ± 0.08 μM, comparable to the standard drug sunitinib (1.2 ± 0.07 μM)." [PMID:40712230]; developer: "Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad 500037, India." [PMID:40712230]; stage: "Among the synthesized derivatives, compound 8u exhibited potent cytotoxicity against the HepG-2 cell line with an IC50 of 1.88 ± 0.83 μM." [PMID:40712230]

02

Targets

VEGFR2 (Vascular endothelial growth factor receptor 2)

Beyond the preview

Go deeper on National Inst. of Pharma Education and Research (NIPER) VEGFR-2 compound 8u.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Inst. of Pharma Education and Research (NIPER) VEGFR-2 compound 8u.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call